BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Dr Reddys Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500124
ISIN Demat
INE089A01031
Book Value (Rs)
377.9559391
NSE Symbol
DRREDDY
Divident Yield %
0.66
Market Cap
(Rs In Cr.)
100,708
P/E (TTM)
32.88
EPS (TTM)
36.69
Face Value
(Rs)
1
Date Heading
10-Jul-26 Dr Reddys Laboratories Ltd slips for fifth straight session
09-Jul-26 Nifty trades above 24,000 level; European mrkt advance
09-Jul-26 Market trade higher; consumer durables shares climb
09-Jul-26 Dr Reddy’s Lab drops after quality issue delays semaglutide supplies
09-Jul-26 Dr Reddys Laboratories Ltd leads losers in 'A' group
29-Jun-26 Dr Reddy's Laboratories gains for sixth straight session
26-Jun-26 Dr Reddy’s Labs receives seven USFDA observations for Hyderabad facili
25-Jun-26 Dr Reddys Laboratories Ltd gains for fifth session
23-Jun-26 Dr Reddys Laboratories to table results
19-Jun-26 Dr Reddys Laboratories allots 6,730 equity shares under ESOP
13-Jun-26 Dr. Reddy’s Labs oncology drug Bosutinib Tablets in United States
05-Jun-26 Dr Reddys Laboratories allots 12,100 equity shares under ESOS
02-Jun-26 Dr Reddys Laboratories Ltd slips for fifth straight session
16-May-26 Dr. Reddy's launches generic Semaglutide Injection in Canada
13-May-26 Stock Alert: Dr Reddys Laboratories, Berger Paints, Dixon Tech, Neulan
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)